APA (7th ed.) Citation

P, M., M, B., K, E., Z, C., R, C., F, F., . . . M, V. d. S. (2016). The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity. British journal of pharmacology, 173(3), 446. https://doi.org/10.1111/bph.13338

Chicago Style (17th ed.) Citation

P, Mukhopadhyay, et al. "The Novel, Orally Available and Peripherally Restricted Selective Cannabinoid CB2 Receptor Agonist LEI-101 Prevents Cisplatin-induced Nephrotoxicity." British Journal of Pharmacology 173, no. 3 (2016): 446. https://doi.org/10.1111/bph.13338.

MLA (9th ed.) Citation

P, Mukhopadhyay, et al. "The Novel, Orally Available and Peripherally Restricted Selective Cannabinoid CB2 Receptor Agonist LEI-101 Prevents Cisplatin-induced Nephrotoxicity." British Journal of Pharmacology, vol. 173, no. 3, 2016, p. 446, https://doi.org/10.1111/bph.13338.